Skip to main content
Gut logoLink to Gut
. 1995 Aug;37(2):242–246. doi: 10.1136/gut.37.2.242

Activated eosinophils and interleukin 5 expression in early recurrence of Crohn's disease.

S Dubucquoi 1, A Janin 1, O Klein 1, P Desreumaux 1, P Quandalle 1, A Cortot 1, M Capron 1, J F Colombel 1
PMCID: PMC1382725  PMID: 7557575

Abstract

Endoscopic recurrences after radical surgery for Crohn's disease are useful for studying the pathogenesis of initial lesions of Crohn's disease. Factors predisposing to recurrence are poorly understood, but it has been shown that eosinophilic infiltration of the neoileum may occur within a few weeks of resection. The aim of this study was to compare, in nine patients having an ileocolectomy, the infiltration of eosinophils and their activation state in normal and diseased areas of the neoileum, three months after surgery. Tissue eosinophils were studied by histochemical methods and electron microscopy. Mucosal expression of interleukin 5 (IL 5), an important eosinophil activating factor was studied using in situ hybridisation. Sixty per cent of patients had endoscopic recurrence at three months. Eosinophil infiltration was more pronounced in diseased than in endoscopically normal areas and was associated with a high expression of IL 5 mRNA. Ultrastructural analysis showed features of eosinophil activation, but no cytotoxic lesions of surrounding inflammatory or epithelial cells. This study suggests that local synthesis of IL 5 associated with eosinophil activation in the tissues could participate in early mucosal damage in Crohn's disease.

Full text

PDF
246

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Breese E., Braegger C. P., Corrigan C. J., Walker-Smith J. A., MacDonald T. T. Interleukin-2- and interferon-gamma-secreting T cells in normal and diseased human intestinal mucosa. Immunology. 1993 Jan;78(1):127–131. [PMC free article] [PubMed] [Google Scholar]
  2. Butterworth A. E., Sturrock R. F., Houba V., Mahmoud A. A., Sher A., Rees P. H. Eosinophils as mediators of antibody-dependent damage to schistosomula. Nature. 1975 Aug 28;256(5520):727–729. doi: 10.1038/256727a0. [DOI] [PubMed] [Google Scholar]
  3. Choy M. Y., Walker-Smith J. A., Williams C. B., MacDonald T. T. Activated eosinophils in chronic inflammatory bowel disease. Lancet. 1990 Jul 14;336(8707):126–127. doi: 10.1016/0140-6736(90)91651-p. [DOI] [PubMed] [Google Scholar]
  4. Colombel J. F., Torpier G., Janin A., Klein O., Cortot A., Capron M. Activated eosinophils in adult coeliac disease: evidence for a local release of major basic protein. Gut. 1992 Sep;33(9):1190–1194. doi: 10.1136/gut.33.9.1190. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Desreumaux P., Janin A., Colombel J. F., Prin L., Plumas J., Emilie D., Torpier G., Capron A., Capron M. Interleukin 5 messenger RNA expression by eosinophils in the intestinal mucosa of patients with coeliac disease. J Exp Med. 1992 Jan 1;175(1):293–296. doi: 10.1084/jem.175.1.293. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Dvorak A. M., Monahan R. A., Osage J. E., Dickersin G. R. Crohn's disease: transmission electron microscopic studies. II. Immunologic inflammatory response. Alterations of mast cells, basophils, eosinophils, and the microvasculature. Hum Pathol. 1980 Nov;11(6):606–619. doi: 10.1016/s0046-8177(80)80072-4. [DOI] [PubMed] [Google Scholar]
  7. Dvorak A. M., Onderdonk A. B., McLeod R. S., Monahan-Earley R. A., Antonioli D. A., Cullen J., Blair J. E., Cisneros R., Letourneau L., Morgan E. Ultrastructural identification of exocytosis of granules from human gut eosinophils in vivo. Int Arch Allergy Immunol. 1993;102(1):33–45. doi: 10.1159/000236548. [DOI] [PubMed] [Google Scholar]
  8. Fujisawa T., Abu-Ghazaleh R., Kita H., Sanderson C. J., Gleich G. J. Regulatory effect of cytokines on eosinophil degranulation. J Immunol. 1990 Jan 15;144(2):642–646. [PubMed] [Google Scholar]
  9. Gleich G. J., Adolphson C. R. The eosinophilic leukocyte: structure and function. Adv Immunol. 1986;39:177–253. doi: 10.1016/s0065-2776(08)60351-x. [DOI] [PubMed] [Google Scholar]
  10. Gleich G. J., Frigas E., Loegering D. A., Wassom D. L., Steinmuller D. Cytotoxic properties of the eosinophil major basic protein. J Immunol. 1979 Dec;123(6):2925–2927. [PubMed] [Google Scholar]
  11. Gurbindo C., Russo P., Sabbah S., Lohoues M. J., Seidman E. Interleukin-2 activity of colonic lamina propria mononuclear cells in a rat model of experimental colitis. Gastroenterology. 1993 Apr;104(4):964–972. doi: 10.1016/0016-5085(93)90262-b. [DOI] [PubMed] [Google Scholar]
  12. Janin A., Torpier G., Capron M., Courtin P., Gosselin B. Immunopathological study of eosinophils in eosinophilic granuloma of bone: evidence for release of three cationic proteins and subsequent uptake in macrophages. Virchows Arch A Pathol Anat Histopathol. 1992;421(3):255–261. doi: 10.1007/BF01611183. [DOI] [PubMed] [Google Scholar]
  13. Janin A., Torpier G., Courtin P., Capron M., Prin L., Tonnel A. B., Hatron P. Y., Gosselin B. Segregation of eosinophil proteins in alveolar macrophage compartments in chronic eosinophilic pneumonia. Thorax. 1993 Jan;48(1):57–62. doi: 10.1136/thx.48.1.57. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Lucey D. R., Nicholson-Weller A., Weller P. F. Mature human eosinophils have the capacity to express HLA-DR. Proc Natl Acad Sci U S A. 1989 Feb;86(4):1348–1351. doi: 10.1073/pnas.86.4.1348. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Mawhorter S. D., Kazura J. W., Boom W. H. Human eosinophils as antigen-presenting cells: relative efficiency for superantigen- and antigen-induced CD4+ T-cell proliferation. Immunology. 1994 Apr;81(4):584–591. [PMC free article] [PubMed] [Google Scholar]
  16. Moy J. N., Gleich G. J., Thomas L. L. Noncytotoxic activation of neutrophils by eosinophil granule major basic protein. Effect on superoxide anion generation and lysosomal enzyme release. J Immunol. 1990 Oct 15;145(8):2626–2632. [PubMed] [Google Scholar]
  17. Murray H. W., Miralles G. D., Stoeckle M. Y., McDermott D. F. Role and effect of IL-2 in experimental visceral leishmaniasis. J Immunol. 1993 Jul 15;151(2):929–938. [PubMed] [Google Scholar]
  18. Olaison G., Smedh K., Sjödahl R. Natural course of Crohn's disease after ileocolic resection: endoscopically visualised ileal ulcers preceding symptoms. Gut. 1992 Mar;33(3):331–335. doi: 10.1136/gut.33.3.331. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Peltz G. A role for CD4+ T-cell subsets producing a selective pattern of lymphokines in the pathogenesis of human chronic inflammatory and allergic diseases. Immunol Rev. 1991 Oct;123:23–35. doi: 10.1111/j.1600-065x.1991.tb00604.x. [DOI] [PubMed] [Google Scholar]
  20. Rutgeerts P., Geboes K., Vantrappen G., Beyls J., Kerremans R., Hiele M. Predictability of the postoperative course of Crohn's disease. Gastroenterology. 1990 Oct;99(4):956–963. doi: 10.1016/0016-5085(90)90613-6. [DOI] [PubMed] [Google Scholar]
  21. Rutgeerts P., Geboes K., Vantrappen G., Kerremans R., Coenegrachts J. L., Coremans G. Natural history of recurrent Crohn's disease at the ileocolonic anastomosis after curative surgery. Gut. 1984 Jun;25(6):665–672. doi: 10.1136/gut.25.6.665. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Spry C. J., Kay A. B., Gleich G. J. Eosinophils 1992. Immunol Today. 1992 Oct;13(10):384–387. doi: 10.1016/0167-5699(92)90085-L. [DOI] [PubMed] [Google Scholar]
  23. Torpier G., Colombel J. F., Mathieu-Chandelier C., Capron M., Dessaint J. P., Cortot A., Paris J. C., Capron A. Eosinophilic gastroenteritis: ultrastructural evidence for a selective release of eosinophil major basic protein. Clin Exp Immunol. 1988 Dec;74(3):404–408. [PMC free article] [PubMed] [Google Scholar]
  24. Wang J. M., Rambaldi A., Biondi A., Chen Z. G., Sanderson C. J., Mantovani A. Recombinant human interleukin 5 is a selective eosinophil chemoattractant. Eur J Immunol. 1989 Apr;19(4):701–705. doi: 10.1002/eji.1830190420. [DOI] [PubMed] [Google Scholar]
  25. Weller P. F. The immunobiology of eosinophils. N Engl J Med. 1991 Apr 18;324(16):1110–1118. doi: 10.1056/NEJM199104183241607. [DOI] [PubMed] [Google Scholar]
  26. Zhu Y., Lukacs N. W., Boros D. L. Cloning of TH0- and TH2-type helper lymphocytes from liver granulomas of Schistosoma mansoni-infected mice. Infect Immun. 1994 Mar;62(3):994–999. doi: 10.1128/iai.62.3.994-999.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES